Planet 13 Holdings (PLNH) Change in Account Payables (2022 - 2026)
Planet 13 Holdings (PLNH) posted quarterly Change in Account Payables of -$483957.0 for Q1 2026, up 69.44% year-over-year from -$285627.8 in Q1 2025, and up 7.43% quarter-over-quarter from -$522790.0 in Q3 2025.
Planet 13 Holdings (PLNH) Change in Account Payables (2022 - 2026) Analysis & Trends
Planet 13 Holdings (PLNH) has reported Change in Account Payables for 5 consecutive years, with -$483957.0 the latest figure, recorded in Q1 2026.
- In Q1 2026, Change in Account Payables rose 69.44% year-over-year to -$483957.0; the TTM figure through Mar 2026 stood at -$1.4 million (down 138.33% YoY), while the FY2024 annual figure was $4.3 million, up 1353.09% from the prior year.
- Change in Account Payables grew to -$483957.0 in Q1 2026 per PLNH's latest filing, from -$522790.0 in the prior quarter.
- Across five years, Change in Account Payables topped out at $2.8 million in Q4 2024 and bottomed at -$1.6 million in Q1 2025.
- Historically, Change in Account Payables has averaged $264201.1 across 5 years, with a median of -$13497.5 in 2023.
- On a YoY basis, Change in Account Payables climbed as much as 4743.38% in 2024 and fell as far as 133.51% in 2024.
- Planet 13 Holdings' Change in Account Payables stood at $387084.0 in 2022, then plunged by 85.05% to $57858.0 in 2023, then jumped by 4743.38% to $2.8 million in 2024, then tumbled by 118.66% to -$522790.0 in 2025, then advanced by 7.43% to -$483957.0 in 2026.
- Business Quant data shows PLNH's Change in Account Payables at -$483957.0 in Q1 2026, -$522790.0 in Q3 2025, and $1.2 million in Q2 2025.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Change in Account Payables (Qtr) |
|---|---|---|---|---|---|
| 1 | Haleon | 43.89 Bn | 42.93 Bn | - | - |
| 2 | Teva Pharmaceutical Industries | 42.98 Bn | 39.33 Bn | 2.15 Bn | - |
| 3 | Zoetis | 31.54 Bn | 29.86 Bn | 1.05 Bn | -53.00 Mn |
| 4 | Takeda Pharmaceutical | 28.61 Bn | 22.81 Bn | 5.10 Bn | -143.74 Mn |
| 5 | United Therapeutics | 22.15 Bn | 19.48 Bn | 683.80 Mn | - |
| 6 | Viatris | 18.75 Bn | 17.86 Bn | 1.46 Bn | -21.20 Mn |
| 7 | Neurocrine Biosciences | 15.56 Bn | 15.17 Bn | 935.80 Mn | - |
| 8 | Elanco Animal Health | 11.74 Bn | 11.21 Bn | 798.00 Mn | - |
| 9 | Dr Reddys Laboratories | 10.11 Bn | 9.95 Bn | - | - |
| 10 | Planet 13 Holdings | 51.22 Mn | 34.74 Mn | 12.32 Mn | -1.73 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Jun 30, 2026 | -1.73 Mn |
| Jun 30, 2026 | -1.73 Mn |
| Mar 31, 2026 | -483,957.00 |
| Mar 31, 2026 | -483,957.00 |
| Sep 30, 2025 | -522,790.00 |
| Sep 30, 2025 | -522,790.00 |
| Jun 30, 2025 | 1.22 Mn |
| Jun 30, 2025 | 1.22 Mn |
| Mar 31, 2025 | -1.58 Mn |
| Mar 31, 2025 | -1.58 Mn |
| Dec 31, 2024 | 2.80 Mn |
| Dec 31, 2024 | 2.80 Mn |
| Sep 30, 2024 | 2.45 Mn |
| Sep 30, 2024 | 2.45 Mn |
| Jun 30, 2024 | -84,853.00 |
| Jun 30, 2024 | -84,853.00 |
| Mar 31, 2024 | -829,695.00 |
| Mar 31, 2024 | -829,695.00 |
| Dec 31, 2023 | 57,858.00 |
| Dec 31, 2023 | 57,858.00 |